The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study
Abstract
AIMS: To characterize contemporary Eisenmenger patients at a large centre for adult congenital heart disease, assess survival prospects, and identify predictors of death in this population. METHODS AND RESULTS: All Eisenmenger patients under follow-up at our centre since 2000 (n=171, mean age 37+/-12 years) were included. To identify predictors of mortality, a case-control study was performed. Data including symptoms, functional class, medication, laboratory, and electrocardiographic and echocardiographic parameters are presented. Iron deficiency was common and strongly related to phlebotomy (relative risk 4.1, P<0.0001). Haemoglobin concentration was inversely related to arterial oxygen saturations in iron-replete patients (P<0.001) but not in iron-deficient patients. During a median follow-up of 67 months, 20 patients died. Survival at 40, 50, and 60 years of age was 94, 74, and 52%, respectively. When compared with healthy individuals, median survival was reduced by approximately 20 years in Eisenmenger patients and was worst in those with complex lesions. Predictors of mortality included functional class, signs of heart failure, history of clinical arrhythmia, QRS duration and QTc interval, and low serum albumin and potassium levels. CONCLUSION: Despite good short-term prognosis, life expectancy is markedly reduced in Eisenmenger patients. Markers of heart failure and parameters associated with arrhythmia are of prognostic value in terms of mortality and may guide clinicians caring for Eisenmenger patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Wood, P. (1958) · BMJ · doi:10.1136/bmj.2.5098.701 · Cited by 605
Eisenmenger syndrome. Factors relating to deterioration and death
Daliento, L., Somerville, J., Presbitero, P., Menti, L., Brach-Prever, S., Rizzoli, G., & Stone, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1046 · Cited by 526
Clinical efficacy of sildenafil in primary pulmonary hypertension
Sastry, B. K. S., Narasimhan, C., Reddy, N. K., & Raju, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.056 · Cited by 488
Hopkins, W. E., Ochoa, L. L., Richardson, G., & Trulock, E. P. (1996) · PubMed · Cited by 444
Bolger, A. P., Sharma, R., Li, W., Leenarts, M., Kalra, P. R., Kemp, M., Coats, A. J. S., Anker, S. D., & Gatzoulis, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000020009.30736.3f · Cited by 419
Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome
SANDOVAL, J., AGUIRRE, J. S., PULIDO, T., MARTINEZ-GUERRA, M. L., SANTOS, E., ALVARADO, P., ROSAS, M., & BAUTISTA, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2106076 · Cited by 213
Use of Sedatives and Neuromuscular Blockers in a Cohort of Patients Receiving Mechanical Ventilation
Arroliga, A., Frutos-Vivar, F., Hall, J., Esteban, A., Apezteguía, C., Anzueto, A., & Soto, L. (2005) · Chest · doi:10.1378/chest.128.2.496 · Cited by 211
Cited by
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)
Endorsed by the Association for European Paediatric Cardiology (AEPC), Authors/Task Force Members, Baumgartner, H., Bonhoeffer, P., De Groot, N. M. S., de Haan, F., Deanfield, J. E., Galie, N., Gatzoulis, M. A., Gohlke-Baerwolf, C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq249 · Cited by 2,331
Mortality in adult congenital heart disease
Verheugt, C. L., Uiterwaal, C. S. P. M., van der Velde, E. T., Meijboom, F. J., Pieper, P. G., van Dijk, A. P. J., Vliegen, H. W., Grobbee, D. E., & Mulder, B. J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq032 · Cited by 617
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
Diller, G.-P., & Gatzoulis, M. A. (2007) · Circulation · doi:10.1161/circulationaha.105.592386 · Cited by 405
Self-citationDimopoulos, K., Inuzuka, R., Goletto, S., Giannakoulas, G., Swan, L., Wort, S. J., & Gatzoulis, M. A. (2010) · Circulation · doi:10.1161/circulationaha.109.883876 · Cited by 388
Metadata
- Authors
- Diller, G.-P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-25
- Volume
- 27
- Issue
- 14
- Pages
- 1737-1742
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2108055336
- Cited by
- 316
- References
- 16
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. https://app.cochat.ai/papers/10.1093/eurheartj/ehl116
- The paper
- Diller, G.-P. (2006). Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehl116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.